Metabolite Profiling of Serum from Patients with Tuberculosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tuberculosis (TB) is a major infectious disease that threatens the life and health of people globally. Here, we performed a metabolomic analysis of serum samples from patients with intractable TB to identify biomarkers that might shorten the TB treatment period. Serum samples collected at the commencement of patients’ treatment and healthy controls were analyzed using the capillary electrophoresis and time-offlight mass spectrometry metabolome analysis method. The analysis identified the metabolites cystine, kynurenine, glyceric acid, and cystathionine, which might be useful markers for monitoring the TB treatment course. Furthermore, our research may provide experimental data to develop potential biomarkers in the TB treatment course.
Abstract
Tuberculosis (TB) is a major infectious disease that threatens the life and health of people globally. Here, we performed a metabolomic analysis of serum samples from patients with intractable TB to identify biomarkers that might shorten the TB treatment period. Serum samples collected at the commencement of patients’ treatment and healthy controls were analyzed using the capillary electrophoresis and time-offlight mass spectrometry metabolome analysis method. The analysis identified the metabolites cystine, kynurenine, glyceric acid, and cystathionine, which might be useful markers for monitoring the TB treatment course. Furthermore, our research may provide experimental data to develop potential biomarkers in the TB treatment course.
참고문헌 (21)
- Lau SK, "Metabolomic profiling of plasma from patients with tuberculosis by use of untargeted mass spectrometry reveals novel biomarkers for diagnosis", J. Clin. Microbiol, 53, pp.3750~3759 (2015)
- Zumla A, "Viewpoint : Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection", Trop. Med. Int. Health, 16, pp.79~83 (2011)
- Nema V, "Tuberculosis diagnostics : Challenges and opportunities", Lung India, 29, pp.259~266 (2012)
- Gautam US, "In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis", Proc. Natl. Acad. Sci. USA, 115, pp.E62~E71 (2018)
- Lange C, "Management of patients with multidrugresistant", extensively drug-resistant tuberculosis in Europe : a TBNET consensus statement, 2014, pp.44, 23~63
- Caulfield AJ, "Diagnosis of active tuberculosis disease : From microscopy to molecular techniques", J. Clin. Tuberc. Other Mycobact. Dis, 4, pp.33~43 (2016)
- Moore DF, "Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by ligase chain reaction", J. Clin. Microbiol, 36, pp.1028~1031 (1998)
- Odubanjo MO, "The microbiological diagnosis of tuberculosis in a resource - limited setting: is acidfast bacilli microscopy alone sufficient?", Ann. Ib. Postgrad. Med, 9, pp.24~29 (2011)
- Huang H, "Plasma metabolites xanthine, 4-pyridoxate, and d-glutamic acid as novel potential biomarkers for pulmonary tuberculosis", Clin. Chim. Acta, 498, pp.135~142 (2019)
- Gupta R, "Tuberculosis as a major global health problem in the 21st century : A WHO perspective", Semin. Respir. Crit. Care Med, 25, pp.245~253 (2004)
- Harries AD, "Challenges and progress with diagnosing pulmonary tuberculosis in low-and middle-income countries", Diagnostics(Basel), 8, pp.78~ (2018)
- Zhang A, "Metabolomics for biomarker discovery : Moving to the clinic", Biomed. Res. Int, 2015, pp.354671~ (2015)
- Shah SH, "Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases : form and function", Circulation, 126, pp.1110~1120 (2012)
- Wang X, "Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease", Mol. Cell. Proteomics, 11, pp.370~380 (2012)
- Engle S, "Unboxing cluster heatmaps", BMC Bioinformatics, 18, pp.63~ (2017)
- Adu-Gyamfi CG, "Diagnostic accuracy of plasma kynurenine", tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis, 2020, pp.99, 441~448
- Burns-Huang K, "Mycobacterium tuberculosis cysteine biosynthesis genes mec+-cysO-cysM confer resistance to clofazimine", Tuberculosis, 115, pp.63~66 (2019)
- Wu H, "Indoleamine 2, 3-dioxygenase regulation of immune response(Review)", Mol. Med. Rep, 17, pp.4867~4873 (2018)
- Du Preez I, "Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance", Drug Metab. Rev, 50, pp.466~481 (2018)
- Saini V, "Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis", Nat. Commun, 11, pp.557~ (2020)
- Mahato S, "A putative cystathionine beta-synthase homolog of Mycobacterium smegmatis is involved in de novo cysteine biosynthesis", FASEB J, 34, pp.1~ (2020)